CRSP

NASDAQ · Biotechnology

Crispr Therapeutics Ag

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$54.36

+0.27 (+0.50%)

Analyst Consensus

Buy

Analysts

Very High

Coverage

Buy 19 59%

Hold 12 38%

Sell 1 3%

Price Target

Analyst Price Target +104.3% upside

Low Target $83.97

Average Target $111.08

High Target $162.31

Current Price $54.36

Current
$54.36

Target
$111.08

$83.97 $111.08 avg $162.31

Scenario Analysis

Bear Case

$83.97

54.5%

Low target

Base Case

$111.08

+104.3%

Avg target

Bull Case

$162.31

+198.6%

High target

Risk/Reward

3.6x

Highly favorable

Price in Context

52-Week High

$78.48

-30.7% from high

52-Week Low

$42.17

+28.9% from low

50-Day SMA

$54.19

+0.3% vs SMA

200-Day SMA

$54.12

+0.4% vs SMA

RSI (14)

52.8

Neutral

Target vs 52W High

$111.08

+41.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+12.0%
AMGN Amgen Inc	Hold	44	50%	$190.87	-44.6%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+190.4%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-6.1%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.5%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-31.2%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-37.5%